기사

(Photo = courtesy of Prodizen)

[Medical Today = Reporter Choi Min-seok] Prodizen won the "1 million dollar export tower" on the 5th.

Prodizen is the first company in Korea to develop and sell PRP, has passed various new medical technologies in the Platelet Rich Plasma (PRP), and is a global cell therapy company certified by the U.S. FDA, China CFDA, and CE.

PRP is plasma that contains a large amount of platelets rich in growth factors. Highly concentrated platelets contain a large amount of growth factors and cytokines that differentiate and regenerate damaged tissue cells, and move cells that can induce wound healing to the wound, enabling safe and rapid healing of damaged areas. 

Prodizen brand 'PROSYS PRP', which means PROHEALTH CARES SYSTEM, is loved not only at home but also abroad based on a simple and fast separation system. In particular, the strength of Prodizen is that all PRP KITs are produced at its GMP facilities, not OEMs, and the technology is patented in Korea, Taiwan, Europe, and the United States. It also recently launched bone marrow enrichment kits, BMC-S30, and BMC-R30.

Recently, under the brand WORLDDPRP, it has completed successful launches in North America and Europe and is actively exporting.

A Prodizen official said, "It is expected that exports will increase further in the future through long-term contracts with clients in North America," adding, "We plan to focus on not only North America but also Asia such as Thailand, UAE, and India in 2024."

Medical Today reporter Choi Min-seok (august@mdtoday.co.kr )